| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 10 |
| 1 | METRONIDAZOLE | 8 |
| 2 | METRONIDAZOLE TOPICAL | 8 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 7 |
| 4 | ATAZANAVIR | 6 |
| 5 | MISOPROSTOL | 6 |
| 6 | RITONAVIR | 6 |
| 7 | USTEKINUMAB | 6 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 5 |
| 9 | ADALIMUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOHPEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0303 |
| 1 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0172 |
| 2 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0028 |
| 3 | SILICON DIOXIDE | 1 | 0.0016 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| 6 | MISOPROSTOL | 6 | 0.0006 |
| 7 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 1 | 0.0006 |
| 8 | ATAZANAVIR | 6 | 0.0004 |
| 9 | MIFEPRISTONE | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 1 | Prostaglandin E1 Analog [EPC] | 6 | 0.0004 |
| 2 | Protease Inhibitor [EPC] | 9 | 0.0002 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 9 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 8 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0001 |
| 9 | Interleukin-12 Antagonist [EPC] | 6 | 0.0001 |